92 related articles for article (PubMed ID: 16612053)
1. Influence of sex on the pharmacokinetics of ciprofloxacin and ofloxacin.
Konieczna L; Chmielewska A; Lamparczyk H
Chemotherapy; 2006; 52(3):111-21. PubMed ID: 16612053
[TBL] [Abstract][Full Text] [Related]
2. Sex-related differences in the pharmacokinetics of oral ciprofloxacin.
Overholser BR; Kays MB; Forrest A; Sowinski KM
J Clin Pharmacol; 2004 Sep; 44(9):1012-22. PubMed ID: 15317829
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetics of ciprofloxacin XR (1000 mg) versus levofloxacin (500 mg) in plasma and urine of male and female healthy volunteers receiving a single oral dose.
Wagenlehner FM; Kinzig-Schippers M; Tischmeyer U; Wagenlehner C; Sörgel F; Dalhoff A; Naber KG
Int J Antimicrob Agents; 2006 Jan; 27(1):7-14. PubMed ID: 16343856
[TBL] [Abstract][Full Text] [Related]
4. Comparative tear concentrations of topically applied ciprofloxacin, ofloxacin, and norfloxacin in human eyes.
Akkan AG; Mutlu I; Ozyazgan S; Gök A; Yigit U; Ozüner Z; Senses V; Pekel H
Int J Clin Pharmacol Ther; 1997 May; 35(5):214-7. PubMed ID: 9174877
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics of the quinolones in volunteers: a proposed dosing schedule.
Wise R; Griggs D; Andrews JM
Rev Infect Dis; 1988; 10 Suppl 1():S83-9. PubMed ID: 3162327
[TBL] [Abstract][Full Text] [Related]
6. Aqueous humour levels of topically applied ciprofloxacin and ofloxacin in the same subjects.
Cekiç O; Batman C; Totan Y; Yasar U; Basci NE; Bozkurt A; Kayaalp SO; Zilelioglu O
Eye (Lond); 1999 Oct; 13 ( Pt 5)():656-9. PubMed ID: 10696321
[TBL] [Abstract][Full Text] [Related]
7. Penetration of ofloxacin and ciprofloxacin in aqueous humor after topical administration.
Cekiç O; Batman C; Totan Y; Yasar U; Basci NE; Bozkurt A; Kayaalp SO
Ophthalmic Surg Lasers; 1999 Jun; 30(6):465-8. PubMed ID: 10392734
[TBL] [Abstract][Full Text] [Related]
8. Concentrations of the des-F(6)-quinolone garenoxacin in plasma and joint cartilage of immature rats.
Kastner M; Rahm U; Baumann-Wilschke I; Bello A; Stahlmann R
Arch Toxicol; 2004 Feb; 78(2):61-7. PubMed ID: 14661070
[TBL] [Abstract][Full Text] [Related]
9. Dose related pharmacokinetics of ofloxacin in healthy volunteers.
Immanuel C; Hemanthkumar AK; Gurumurthy P; Venkatesan P
Int J Tuberc Lung Dis; 2002 Nov; 6(11):1017-22. PubMed ID: 12475149
[TBL] [Abstract][Full Text] [Related]
10. Comparative pharmacokinetics of ofloxacin and ciprofloxacin.
Wolfson JS; Hooper DC
Am J Med; 1989 Dec; 87(6C):31S-36S. PubMed ID: 2690617
[TBL] [Abstract][Full Text] [Related]
11. Gender differences on bioavailabity of ofloxacin.
Zulfiqar-ul-Hassan ; Riffat S; Naseer R
J Ayub Med Coll Abbottabad; 2008; 20(2):114-7. PubMed ID: 19385473
[TBL] [Abstract][Full Text] [Related]
12. Effect of two balanced salt solutions on the bioavailability of ofloxacin and ciprofloxacin.
Osato MS
Adv Ther; 1999; 16(5):200-9. PubMed ID: 10915395
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics of topically applied ciprofloxacin in rabbit tears.
Green LC; Callegan MC; Engel LS; Shimomura Y; Jasheway DW; O'Callaghan RJ; Hill JM
Jpn J Ophthalmol; 1996; 40(1):123-6. PubMed ID: 8739510
[TBL] [Abstract][Full Text] [Related]
14. An in vivo study comparing the ocular absorption of levofloxacin and ciprofloxacin prior to phacoemulsification.
Bucci FA
Am J Ophthalmol; 2004 Feb; 137(2):308-12. PubMed ID: 14962422
[TBL] [Abstract][Full Text] [Related]
15. Ciprofloxacin and ofloxacin aqueous humor concentrations after topical administration in dogs undergoing cataract surgery.
Yu-Speight AW; Kern TJ; Erb HN
Vet Ophthalmol; 2005; 8(3):181-7. PubMed ID: 15910371
[TBL] [Abstract][Full Text] [Related]
16. The pharmacokinetics of oral quinolones (norfloxacin, ciprofloxacin, ofloxacin).
Alestig K
Scand J Infect Dis Suppl; 1990; 68():19-22. PubMed ID: 2218417
[TBL] [Abstract][Full Text] [Related]
17. Aqueous and vitreous penetration of topically applied ciprofloxacin and ofloxacin.
Taustine LR
J Cataract Refract Surg; 2004 Jan; 30(1):6. PubMed ID: 14967251
[No Abstract] [Full Text] [Related]
18. Comparison of ciprofloxacin and ofloxacin using human corneal susceptibility levels.
Kowalski RP; Karenchak LM; Gordon YJ
Cornea; 1998 May; 17(3):282-7. PubMed ID: 9603384
[TBL] [Abstract][Full Text] [Related]
19. Concentrations in plasma, urinary excretion and bactericidal activity of levofloxacin (500 mg) versus ciprofloxacin (500 mg) in healthy volunteers receiving a single oral dose.
Wagenlehner FM; Kinzig-Schippers M; Sörgel F; Weidner W; Naber KG
Int J Antimicrob Agents; 2006 Dec; 28(6):551-9. PubMed ID: 17101261
[TBL] [Abstract][Full Text] [Related]
20. Bioequivalence evaluation of 2 different oral formulations of ciprofloxacin in healthy volunteers.
Galicia I; Frias-Iniesta J; Carcas AJ; Soto A; Gomez E; Miranda E; Fernandez A; Montuenga C
Int J Clin Pharmacol Ther; 1998 May; 36(5):282-5. PubMed ID: 9629993
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
